26/01/2009 (Agence Europe) - The European Medicines Agency has made recommendations for the safer use of Ritalin and other methylphenidate-containing medicines in the EU. The agency has concluded that these medicines remain suitable for the treatment of children aged six or older and adolescents with attention deficit/hyperactivity disorder (ADHD). It recommends, however, that product information should be contain further information, inter alia (1) before treatment, all patients should be...